These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 15848563)

  • 1. Excellent results with calcineurin inhibitor-free initial immunosuppression in old recipients of old kidneys.
    Bösmüller C; Ollinger R; Mark W; Brandacher G; Schneeberger S; Cakar F; Bonatti H; Margreiter R
    Transplant Proc; 2005 Mar; 37(2):881-3. PubMed ID: 15848563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of induction modality on the outcome of deceased donor kidney transplant recipients discharged on steroid-free maintenance immunosuppression.
    Sureshkumar KK; Thai NL; Hussain SM; Ko TY; Marcus RJ
    Transplantation; 2012 Apr; 93(8):799-805. PubMed ID: 22290269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ
    Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcineurin inhibitor-free immunosuppression in dual kidney transplantation from elderly donors.
    Furian L; Baldan N; Margani G; Ekser B; Silvestre C; Marchini F; Bonfante L; Rossi B; Valente ML; Rigotti P
    Clin Transplant; 2007; 21(1):57-62. PubMed ID: 17302592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcineurin inhibitor-free immunosuppression in renal transplantation.
    Parada B; Mota A; Nunes P; Macário F; Pratas J; Bastos C; Figueiredo A
    Transplant Proc; 2005; 37(6):2759-61. PubMed ID: 16182803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a calcineurin-inhibitor-free immunosuppressive protocol in renal transplant recipients of expanded criteria deceased donors.
    Re LS; Rial MC; Guardia OE; Galdo MT; Casadei DH
    Transplant Proc; 2006 Dec; 38(10):3468-9. PubMed ID: 17175306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcineurin-free protocols with basiliximab induction allow patients included in "old to old" programs achieve standard kidney transplant function.
    Emparan C; Laukötter M; Wolters H; Dame C; Heidenreich S; Senninger N
    Transplant Proc; 2003 Jun; 35(4):1326-7. PubMed ID: 12826150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
    Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J
    Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A calcineurin antagonist-free induction/maintenance strategy for immunosuppression in elderly recipients of renal allografts from elderly cadaver donors: long-term results from a prospective single centre trial.
    Arbogast H; Hückelheim H; Schneeberger H; Illner WD; Tarabichi A; Fertmann J; Wimmer CD; Hillebrand GF; Mistry-Burchardi N; Thomae R; Acikgöz A; Land W
    Clin Transplant; 2005 Jun; 19(3):309-15. PubMed ID: 15877790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs.
    Flechner SM; Goldfarb D; Solez K; Modlin CS; Mastroianni B; Savas K; Babineau D; Kurian S; Salomon D; Novick AC; Cook DJ
    Transplantation; 2007 Apr; 83(7):883-92. PubMed ID: 17460558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunosuppression for kidney transplant recipients: current strategies].
    Alberú J; Urrea EM
    Rev Invest Clin; 2005; 57(2):213-24. PubMed ID: 16524061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term results under three different immunosuppressive regimens at one center.
    Schaefer HM; Kizilisik AT; Feurer I; Nylander WA; Langone AJ; Helderman JH; Shaffer D
    Transplant Proc; 2006 Dec; 38(10):3466-7. PubMed ID: 17175305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients.
    Asberg A; Midtvedt K; Line PD; Narverud J; Holdaas H; Jenssen T; Reisaeter AV; Johnsen LF; Fauchald P; Hartmann A
    Transplantation; 2006 Jul; 82(1):62-8. PubMed ID: 16861943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcineurin inhibitor avoidance versus steroid avoidance following kidney transplantation: Postoperative complications.
    Shaffer D; Kizilisik AT; Feurer I; Nylander WA; Helderman JH; Langone AJ; Schaefer HM
    Transplant Proc; 2006 Dec; 38(10):3464-5. PubMed ID: 17175304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus/mycophenolate mofetil-based immunosuppression in aged kidney transplant. A prospective study.
    Solà R; Guirado L; Díaz JM; Facundo C; Gich I; Chuy E; Cabezas A
    Int Immunopharmacol; 2005 Jan; 5(1):129-31. PubMed ID: 15589471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients.
    Groetzner J; Kaczmarek I; Landwehr P; Mueller M; Daebritz S; Lamm P; Meiser B; Reichart B
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):333-41. PubMed ID: 15019657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can we maintain immunosuppression avoiding nephrotoxic agents in pancreas transplantation?
    Kandaswamy R; Dunn T; Humar A; Sutherland DE
    Transplant Proc; 2008 Mar; 40(2):516-7. PubMed ID: 18374118
    [No Abstract]   [Full Text] [Related]  

  • 18. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential quadruple immunosuppression including sirolimus in extended criteria and nonheartbeating donor kidney transplantation.
    Diekmann F; Campistol JM; Saval N; Gutiérrez-Dalmau A; Arellano EM; Crespo M; Rossich E; Esforzado N; Cofán F; Ricart MJ; Torregrosa JV; Oppenheimer F
    Transplantation; 2007 Aug; 84(3):429-32. PubMed ID: 17700171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is complete avoidance of calcineurin inhibitors or steroids now possible? Importance of patient selection and choice of regimen.
    Vincenti F
    Transplant Proc; 2001 Jun; 33(4 Suppl):11S-18S. PubMed ID: 11406263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.